Although erythropoietin may have a role in the management of RBV-related anemia, a recent study failed to show an improvement of SVR in genotype 1-infected patients who were given epoetin alpha at the initiation of therapy to maintain hemoglobin levels between 12 and 15 g/dL (35). Here, EPO is linked to anemia (phenotype).